| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advances and challenges in precision imaging
|
Hricak, Hedvig
|
|
|
26 |
1 |
p. e34-e45
|
article
|
| 2 |
Africa renews commitment to an accelerated plan to end cervical cancer by 2030
|
Makoni, Munyaradzi
|
|
|
26 |
1 |
p. 20
|
article
|
| 3 |
Bangladesh faces serious air pollution crisis
|
Das, Manjulika
|
|
|
26 |
1 |
p. 18
|
article
|
| 4 |
Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma (LITESPARK-003): an open-label, single-arm, phase 2 study
|
Choueiri, Toni K
|
|
|
26 |
1 |
p. 64-73
|
article
|
| 5 |
Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial
|
Xu, Yanjun
|
|
|
26 |
1 |
p. 74-84
|
article
|
| 6 |
Carcinogenicity of hydrochlorothiazide, voriconazole, and tacrolimus
|
Cogliano, Vincent J
|
|
|
26 |
1 |
p. 15-16
|
article
|
| 7 |
Carolyn Taylor and Global Focus on Cancer
|
Reeves, Cheryl
|
|
|
26 |
1 |
p. 23
|
article
|
| 8 |
Colorectal cancer incidence trends in younger versus older adults: an analysis of population-based cancer registry data
|
Sung, Hyuna
|
|
|
26 |
1 |
p. 51-63
|
article
|
| 9 |
Correction to Lancet Oncol 2024; 25: 1625–34
|
|
|
|
26 |
1 |
p. e11
|
article
|
| 10 |
Correction to Lancet Oncol 2024; published online Dec 12. https://doi.org/10.1016/S1470-2045(24)00719-8
|
|
|
|
26 |
1 |
p. e11
|
article
|
| 11 |
Deep learning using histological images for gene mutation prediction in lung cancer: a multicentre retrospective study
|
Zhao, Yu
|
|
|
26 |
1 |
p. 136-146
|
article
|
| 12 |
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
|
Chen, Xiu-Chun
|
|
|
26 |
1 |
p. 27-36
|
article
|
| 13 |
Electronic patient-reported outcomes for CAR T-cell therapies
|
Lapen, Kaitlyn
|
|
|
26 |
1 |
p. e6
|
article
|
| 14 |
Evidence for a reduction in number of cycles of immune checkpoint inhibitors
|
Bazarbachi, Abdul-Hamid
|
|
|
26 |
1 |
p. 9-11
|
article
|
| 15 |
FNAB samples with the STRAT4 assay for breast cancer diagnosis
|
Li, Liqi
|
|
|
26 |
1 |
p. e9
|
article
|
| 16 |
FNAB samples with the STRAT4 assay for breast cancer diagnosis – Authors' reply
|
Ng, Dianna L
|
|
|
26 |
1 |
p. e10
|
article
|
| 17 |
Full-dose SBRT for the primary tumour in stage III NSCLC: a promising and safe way to selective dose escalation?
|
Le Pechoux, Cécile
|
|
|
26 |
1 |
p. 3-5
|
article
|
| 18 |
Hodgkin lymphoma therapy: minimising clinical and biological harms
|
Viviani, Simonetta
|
|
|
26 |
1 |
p. 5-7
|
article
|
| 19 |
I'm Still Me: the many faces of cancer
|
Stirrups, Robert
|
|
|
26 |
1 |
p. 24-26
|
article
|
| 20 |
Integrating cancer into crisis: a global vision for action from WHO and partners
|
Casolino, Raffaella
|
|
|
26 |
1 |
p. e55-e66
|
article
|
| 21 |
Lung cancer rates highest among British Bangladeshi men
|
Gourd, Elizabeth
|
|
|
26 |
1 |
p. 17
|
article
|
| 22 |
Molecular imaging targeting carbonic anhydrase 9 in clear-cell renal cell carcinoma: more than meets the eye
|
Larcher, Alessandro
|
|
|
26 |
1 |
p. e1
|
article
|
| 23 |
Neoadjuvant or perioperative therapy for melanoma metastasis in clinical practice: an international survey
|
Hauschild, Axel
|
|
|
26 |
1 |
p. 12-14
|
article
|
| 24 |
Non-inferiority trials: tyranny or good governance?
|
Freidlin, Boris
|
|
|
26 |
1 |
p. e7
|
article
|
| 25 |
Non-inferiority trials: tyranny or good governance? – Authors' reply
|
Tannock, Ian F
|
|
|
26 |
1 |
p. e8
|
article
|
| 26 |
Optimising therapy and avoiding overtreatment in breast cancer
|
Henry, N Lynn
|
|
|
26 |
1 |
p. 2-3
|
article
|
| 27 |
Pesticide exposure and increased risk of breast cancer for women in rural Brazil
|
Gruber, Karl
|
|
|
26 |
1 |
p. e12
|
article
|
| 28 |
Pharmacy closures in the USA and Europe
|
Devi, Sharmila
|
|
|
26 |
1 |
p. 21
|
article
|
| 29 |
Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single-arm, phase 2 trial
|
Heinzerling, John H
|
|
|
26 |
1 |
p. 85-97
|
article
|
| 30 |
Prior authorisation is can harm patients with cancer in the USA
|
Gruber, Karl
|
|
|
26 |
1 |
p. 22
|
article
|
| 31 |
Prioritising oral health in cancer care
|
The Lancet Oncology,
|
|
|
26 |
1 |
p. 1
|
article
|
| 32 |
Pulmonary neuroendocrine neoplasms: the molecular landscape, therapeutic challenges, and diagnosis and management strategies
|
Sen, Triparna
|
|
|
26 |
1 |
p. e13-e33
|
article
|
| 33 |
Risk-prediction models and clinical challenges in the ROCketS study
|
Crawford, S Michael
|
|
|
26 |
1 |
p. e3
|
article
|
| 34 |
Risk-prediction models and clinical challenges in the ROCkeTS study
|
Feng, Bei
|
|
|
26 |
1 |
p. e2
|
article
|
| 35 |
Risk-prediction models and clinical challenges in the ROCkeTS study – Authors' reply
|
Sundar, Sudha
|
|
|
26 |
1 |
p. e4-e5
|
article
|
| 36 |
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
|
Iyer, Swaminathan P
|
|
|
26 |
1 |
p. 110-122
|
article
|
| 37 |
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial
|
Meattini, Icro
|
|
|
26 |
1 |
p. 37-50
|
article
|
| 38 |
Smoke-free generation a step closer in the UK
|
Kirby, Tony
|
|
|
26 |
1 |
p. 19
|
article
|
| 39 |
Strengthening medical imaging capacity: the time is now
|
Hricak, Hedvig
|
|
|
26 |
1 |
p. 7-9
|
article
|
| 40 |
The changing global landscape of national cancer control plans
|
Romero, Yannick
|
|
|
26 |
1 |
p. e46-e54
|
article
|
| 41 |
The genomic and clinical consequences of replacing procarbazine with dacarbazine in escalated BEACOPP for Hodgkin lymphoma: a retrospective, observational study
|
Santarsieri, Anna
|
|
|
26 |
1 |
p. 98-109
|
article
|
| 42 |
The landscape of primary mismatch repair deficient gliomas in children, adolescents, and young adults: a multi-cohort study
|
Negm, Logine
|
|
|
26 |
1 |
p. 123-135
|
article
|
Journal description